The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kashezhev A.G.

Russia Medical Academy of Cоntinuing Professional Education, Moscow, Russia

Sinkin M.V.

N.V. Sklifosovsky First Aid Scientific Research Institute, Moscow, Russia

Skripkina N.A.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva;
Tsentr kstrapiramidnykh zabolevaniĭ, Moskva

The use of transcranial magnetic stimulation in treatment of affective disorders in Parkinson’s disease

Authors:

Kashezhev A.G., Sinkin M.V., Skripkina N.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(6‑2): 66‑69

DOI: 10.17116/jnevro20171176266-69

Read: 1353 times

Contact the author
Table of contents

THE USE OF TRANSCRANIAL MAGNETIC STIMULATION IN TREATMENT OF AFFECTIVE DISORDERS IN PARKINSON’S DISEASE
THE USE OF TRANSCRANIAL MAGNETIC STIMULATION IN TREATMENT OF AFFECTIVE DISORDERS IN PARKINSON’S DISEASE

To cite this article:

Kashezhev AG, Sinkin MV, Skripkina NA. The use of transcranial magnetic stimulation in treatment of affective disorders in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(6‑2):66‑69. (In Russ.)
https://doi.org/10.17116/jnevro20171176266-69

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Sleep diso­rders in patients with Lewy body deme­ntia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):81-87
Identification of depression biomarkers: Prospects for use in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):51-55
Reorganization of the corticospinal tract and thalamocortical projections in children with sequelae of severe traumatic brain injury. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):56-61
Early diagnosis and effe­ctive therapy of diabetic poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68
Depression Anxiety Stress Scale (russian language version). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):103-107
Inve­stigation of the rela­tionship of indi­vidual characteristics of the brain bioelectrical acti­vity with levels of mental stress, aggression, anxiety, and depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):108-117
Portopulmonary hype­rtension. Journal of Respiratory Medi­cine. 2025;(2):39-44
Diagnosis and treatment of ovarian cancer in pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):27-33
Gender characteristics of cardiovascular diseases psychosocial risk factors asso­ciations with sleep quality in an open urban popu­lation. Russian Journal of Preventive Medi­cine. 2025;(6):67-73
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12
Abstract:

In this literature review, the authors summarize the data on affective disorders in Parkinson’s disease (frequency, clinical presentations, treatment), the results on using transcranial magnetic stimulation, its safety in Parkinson’s disease.

Keywords:

Parkinson’s disease
affective disorders
depression
treatment
transcortical magnetic stimulation

Authors:

Kashezhev A.G.

Russia Medical Academy of Cоntinuing Professional Education, Moscow, Russia

Sinkin M.V.

N.V. Sklifosovsky First Aid Scientific Research Institute, Moscow, Russia

Skripkina N.A.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva;
Tsentr kstrapiramidnykh zabolevaniĭ, Moskva

Close metadata

References:

  1. Levin OS, Dokadina LV. Epidemiologiya parkinsonizma i bolezni Parkinsona. Nevrol zhurn. 2005;10: 5:41-49. (In Russ.).
  2. Levin OS, Fedorova NV. Bolezn’ Parkinsona. Monografiya. 2-е izd. M.: MEDpress-inform; 2012. (In Russ.).
  3. Illarioshkin S.N., Levin O.S. Bolezn’ Parkinsona i rasstroistva dvizhenii. Pod red. Illarioshkina S.N., Levina O.S. M.: ZAO «RKI Sovero press»; 2014. (In Russ.).
  4. Aarsland D, Kurz М. The epidemiology of dementia associated with Parkinson disease. Journal of the Neurological Scieces. 2010;289(1-2):18-22. https://doi.org/10.1016/j.jns.2009.08.034
  5. Ardouin C, Chereau I, Llorca P et al. Assessment of hyper- and hypodopaminergic behaviors in Parkinson’s disease. Revue Neurologique. 2009;165(11):845-856. https://doi.org/10.1016/j .neurol.2009.06.003
  6. Reijnders J, Ehrt U, Weber W, Aarsland D, Leentjens A. A systematic review of prevalence studies of depression in Parkinson’s disease. Movement Disorders. 2007;23(2):183-189. https://doi.org/10.1002/mds.21803
  7. Inoue T, Kitagawa M, Tanaka T, Nakagawa S, Koyama T. Depression and major depressive disorder in patients with Parkinson’s disease. Movement Disorders. 2009;25(l):44-49. https://doi.org/10.1002/mds.22921
  8. Ishihara L, Brayne C. A systematic review of depression and mental illness preceding Parkinson’s disease. Acta Neurologica Scandinavica. 2006;113(4):211-220. https://doi.org/10.1111/j.1600-0404.2006.00579.x
  9. Marsh L. Depression and Parkinson’s Disease: Current Knowledge. Current Neurology and Neuroscience Reports. 2013;13(12). https://doi.org/10.1007/s 11910-013-0409-5
  10. Nilsson F, Kessing L, Sorensen T, Andersen P, Bolwig T. Major depressive disorder in Parkinson’s disease: a register-based study. Acta Psychiatrica Scandinavica. 2002;106(3):202-211. https://doi.org/10.1034/j.l600-0447.2002.02229.x
  11. Aarsland D, Bronnick K, Ehrt U et al. Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress. Journal of Neurology, Neurosurgery & Psychiatry. 2007;78(l):36-42. https://doi.org/10.1136/jnnp.2005.083113
  12. Starkstein S, Merello M, Jorge R et al. A validation study of depressive syndromes in Parkinson’sdisease. Movement Disorders. 2008;23(4):538-546. https://doi.org/10.1002/mds.21866
  13. Brown A, Gershon S. Dopamine and depression. Journal of Neural Transmission. 1993;91(2-3):75-109. https://doi.org/10.1007/bfO1245227
  14. Mayeux R. Altered serotonin metabolism in depressed patients with Parkinson’s disease. Neurology. 1984;34(5):642-642. https://doi.org/10.1212/wnl.34.5.642
  15. Mayeux R. The «serotonin hypothesis» for depression in Parkinson’s disease. Advances in neurology. 1990;53:163.
  16. Mayberg H, Starkstein S. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson’s disease. Annals of Neurology. 1990;28(1):57-64. https://doi.org/10.1002/ana.410280111
  17. Ring H, Bench C. Depression in Parkinson’s disease. A positron emission study. The British Journal of Psychiatry. 1994;165(3):333-339. https://doi.org/10.1192/bjp.l65.3.333
  18. Burn D. Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson’s disease. Movement Disorders. 2002;17(3):445-454. https://doi.org/10.1002/mds.l0114
  19. Levin OS. Bolezn’ Parkinsona kak neiropsikhiatricheskoe zabolevanie. Nevrologiya/revmatologiya. 2011;2:18-22. (In Russ.).
  20. Frisina P, Tenenbaum H, Borod J, Foldi N. The Effects of Antidepressants in Parkinson’s Disease: A Meta-Analysis. International Journal of Neuroscience. 2008;118(5):667-682. https://doi.org/10.1080/00207450701239418
  21. Ben-Shachar D, Belmaker R, Grisaru N, Klein E. Transcranial magnetic stimulation induces alterations in brain monoamines. Journal of Neural Transmission. 1997;104(2-3):191-197. https://doi.org/10.1007/bfO1273180
  22. Pal E, Nagy F, Aschermann Z, Balazs E, Kovacs N. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson’s disease: A randomized, double-blind, placebo-controlled study. Movement Disorders. 2010;25(14):2311-2317. https://doi.org/10.1002/mds.23270
  23. Makkos A, Pal E, Aschermann Z et al. High-Frequency Repetitive Transcranial Magnetic Stimulation Can Improve Depression in Parkinson’s Disease: A Randomized, Double-Blind, Placebo-Controlled Study. Neuropsychobiology. 2016;73(3):169-177. https://doi.org/10.1159/000445296
  24. Shin H, Youn Y, Chung S, Sohn Y. Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson’s disease. Journal of Neurology. 2016;263(7):1442-1448. https://doi.org/10.1007/s00415-016-8160-х
  25. Xie С, Chen J, Wang X et al. Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in Parkinson’s disease: a meta-analysis of randomized controlled clinical trials. Neurological Sciences. 2015;36(10):1751-1761. https://doi.org/10.1007/sl0072-015-2345-4
  26. Lefaucheur J, Andre-Obadia N, Antal A et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiology. 2014;125(11):2150-2206. https://doi.org/10.1016/j.clinph.2014.05.021
  27. Brys M, Fox M, Agarwal S et al. Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease. Neurology. 2016;87(18):1907-1915. https://doi.org/10.1212/wnl.0000000000003279
  28. Cardoso E, Fregni F, Martins Maia F et al. rTMS treatment for depression in Parkinson’s disease increases BOLD responses in the left prefrontal cortex. The International Journal of Neuropsychopharmacology. 2007;11(02). https://doi.org/10.1017/sl461145707007961
  29. VonLoh M, Chen R, Kluger B. Safety of transcranial magnetic stimulation in Parkinson’s disease: A review of the literature. Parkinsonism & Related Disorders. 2013;19(6):573-585. https://doi.org/10.1016/j .parkreldis.2013.01.007
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.